MARKER THERAPEUTICS, INC. Proceeds from Issuance of Warrants
MARKER THERAPEUTICS, INC. (MRKR) reported Proceeds from Issuance of Warrants of $600.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2022-03-17
- MARKER THERAPEUTICS, INC. proceeds from issuance of warrants for the quarter ending 2020-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. proceeds from issuance of warrants for the quarter ending 2020-09-30 was $0.00.
- MARKER THERAPEUTICS, INC. proceeds from issuance of warrants for fiscal 2020 was $600.00K, a 25.00% decline from fiscal 2019.
- MARKER THERAPEUTICS, INC. proceeds from issuance of warrants for fiscal 2019 was $800.00K, a 66.67% decline from fiscal 2018.
- MARKER THERAPEUTICS, INC. proceeds from issuance of warrants for fiscal 2018 was $2.40M.
| Period end | Proceeds from Issuance of Warrants 0 month | Proceeds from Issuance of Warrants 1 month | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month | Proceeds from Issuance of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $600.00K 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $600.00K 10-Q · filed 2020-11-09 | |||||
| 2020-06-30 | $600.00K 10-Q · filed 2020-08-10 | ||||||
| 2020-03-31 | $600.00K 10-Q · filed 2020-05-11 | ||||||
| 2019-12-31 | $800.00K 10-K · filed 2021-03-09 | $759.00K 10-K · filed 2020-03-12 | |||||
| 2018-12-31 | $2.40M 10-K · filed 2020-03-12 | ||||||
| 2018-05-14 | $2.00M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |